Effects of the Slow-release Curcumin-loaded Selenium Nanoparticles on Experimental Peritonitis

Abstract

Background: New pharmaceutical forms of natural compounds such as curcumin can be an effective intervention to control peritonitis and abdominal adhesion. Objectives: This study investigates the effects of slow-release curcumin-loaded selenium nanoparticles (Cur@S.N) on some inflammatory biomarkers in experimental peritonitis. Methods: After synthesizing selenium nanoparticles (S.N) and (Cur@S.N), experimental peritonitis was surgically induced in 80 adult male rats. The control group received no treatment, whereas the other groups received single intraperitoneal doses of 0.25 mg/kg S.N, 50 mg/kg curcumin, and 0.25+50 mg/kg (Cur@S.N). Blood malondialdehyde (MDA), nitric oxide (NO), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNFα) were measured on days 3, 7 and 14, and also intra-abdominal adhesion assessment was done. Results: On day 3, NO levels in all treatment groups significantly decreased (P>0.05), while the lowest level was seen on day 14 in the S.N group (P˂0.05). MDA was significantly lower in the S.N and Cur@S.N groups than in the control on days 3, 7 and 14 (P˂0.05). TNF-α levels in S.N and Cur@S.N groups were significantly lower than in the control group on day 3 (P≤0.05). Meanwhile, the S.N group had the lowest level on day 14. IL-6 significantly decreased on days 3 and 7 in the Cur@S.N and curcumin groups compared to the control group (P˂0.05). Conclusion: Cur@S.N group possesses significant anti-inflammatory efficacy by reducing MDA, NO, IL-6 and TNF-α, decreasing peritonitis and intra-abdominal adhesion.